9188 related articles for article (PubMed ID: 14720384)
21. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of p73 and p53 in human cancer cell lines.
Yoshikawa H; Nagashima M; Khan MA; McMenamin MG; Hagiwara K; Harris CC
Oncogene; 1999 Jun; 18(22):3415-21. PubMed ID: 10362363
[TBL] [Abstract][Full Text] [Related]
23. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
[TBL] [Abstract][Full Text] [Related]
24. p73 and p53 pathway in human breast cancers.
Bozzetti C; Nizzoli R; Musolino A; Martella EM; Crafa P; Lagrasta CA; Camisa R; Bonati A; Lunghi P; Ardizzoni A
J Clin Oncol; 2007 Apr; 25(11):1451-3; author reply 1453-4. PubMed ID: 17416871
[No Abstract] [Full Text] [Related]
25. p73 mutations are not detected in sporadic and hereditary breast cancer.
Schwartz DI; Lindor NM; Walsh-Vockley C; Roche PC; Mai M; Smith DI; Liu W; Couch FJ
Breast Cancer Res Treat; 1999 Nov; 58(1):25-9. PubMed ID: 10634515
[TBL] [Abstract][Full Text] [Related]
26. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype.
Yokozaki H; Shitara Y; Fujimoto J; Hiyama T; Yasui W; Tahara E
Int J Cancer; 1999 Oct; 83(2):192-6. PubMed ID: 10471526
[TBL] [Abstract][Full Text] [Related]
27. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
28. Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines.
Schittek B; Sauer B; Garbe C
Int J Cancer; 1999 Aug; 82(4):583-6. PubMed ID: 10404074
[TBL] [Abstract][Full Text] [Related]
29. Role of p73 in malignancy: tumor suppressor or oncogene?
Stiewe T; Pützer BM
Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
[TBL] [Abstract][Full Text] [Related]
30. Biological and clinical role of p73 in neuroblastoma.
Romani M; Tonini GP; Banelli B; Allemanni G; Mazzocco K; Scaruffi P; Boni L; Ponzoni M; Pagnan G; Raffaghello L; Ferrini S; Croce M; Casciano I
Cancer Lett; 2003 Jul; 197(1-2):111-7. PubMed ID: 12880969
[TBL] [Abstract][Full Text] [Related]
31. p73, a gene related to p53, is not mutated in esophageal carcinomas.
Nimura Y; Mihara M; Ichimiya S; Sakiyama S; Seki N; Ohira M; Nomura N; Fujimori M; Adachi W; Amano J; He M; Ping YM; Nakagawara A
Int J Cancer; 1998 Nov; 78(4):437-40. PubMed ID: 9797131
[TBL] [Abstract][Full Text] [Related]
32. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
[TBL] [Abstract][Full Text] [Related]
33. Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas.
Kroiss MM; Bosserhoff AK; Vogt T; Buettner R; Bogenrieder T; Landthaler M; Stolz W
Melanoma Res; 1998 Dec; 8(6):504-9. PubMed ID: 9918412
[TBL] [Abstract][Full Text] [Related]
34. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.
Kovalev S; Marchenko N; Swendeman S; LaQuaglia M; Moll UM
Cell Growth Differ; 1998 Nov; 9(11):897-903. PubMed ID: 9831242
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the p73 gene in human breast cancers.
Shishikura T; Ichimiya S; Ozaki T; Nimura Y; Kageyama H; Nakamura Y; Sakiyama S; Miyauchi M; Yamamoto N; Suzuki M; Nakajima N; Nakagawara A
Int J Cancer; 1999 Jun; 84(3):321-5. PubMed ID: 10371354
[TBL] [Abstract][Full Text] [Related]
36. [Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma].
Ge H; Wang YM; Cao YY; Zhang XF; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2006 Nov; 25(11):1351-5. PubMed ID: 17094900
[TBL] [Abstract][Full Text] [Related]
37. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
38. p73 is up-regulated in a subset of hepatocellular carcinomas.
Herath NI; Kew MC; Whitehall VL; Walsh MD; Jass JR; Khanna KK; Young J; Powell LW; Leggett BA; Macdonald GA
Hepatology; 2000 Mar; 31(3):601-5. PubMed ID: 10706549
[TBL] [Abstract][Full Text] [Related]
39. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
[TBL] [Abstract][Full Text] [Related]
40. Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumours.
Norris MD; Gilbert J; Smith SA; Marshall GM; Salwen H; Cohn SL; Haber M
Med Pediatr Oncol; 2001 Jan; 36(1):48-51. PubMed ID: 11464904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
